These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 12933585
1. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE. Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD. Blood; 2003 Dec 15; 102(13):4464-71. PubMed ID: 12933585 [Abstract] [Full Text] [Related]
6. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS. Lee JH, Halperin-Sheinfeld M, Baatar D, Mughal MR, Tae HJ, Kim JW, Carter A, Lustig A, Snir O, Lavie G, Okun E, Mattson MP, Sredni B, Taub DD. Neuromolecular Med; 2014 Jun 15; 16(2):292-307. PubMed ID: 24272426 [Abstract] [Full Text] [Related]
8. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis. Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M. Immunol Invest; 2015 Jun 15; 44(7):694-712. PubMed ID: 26436854 [Abstract] [Full Text] [Related]
10. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis. Pyka-Fościak G, Lis GJ, Litwin JA. Int J Mol Sci; 2022 Apr 22; 23(9):. PubMed ID: 35563027 [Abstract] [Full Text] [Related]
12. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. J Neuroimmunol; 1992 Jun 22; 38(3):229-40. PubMed ID: 1376328 [Abstract] [Full Text] [Related]
13. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. J Immunol; 2002 Apr 15; 168(8):4173-83. PubMed ID: 11937578 [Abstract] [Full Text] [Related]
14. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. Howard LM, Dal Canto MC, Miller SD. J Neuroimmunol; 2002 Aug 15; 129(1-2):58-65. PubMed ID: 12161021 [Abstract] [Full Text] [Related]
15. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes. Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H. J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903 [Abstract] [Full Text] [Related]
16. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis. Tietz S, Périnat T, Greene G, Enzmann G, Deutsch U, Adams R, Imhof B, Aurrand-Lions M, Engelhardt B. Brain Behav Immun; 2018 Oct 15; 73():3-20. PubMed ID: 29920328 [Abstract] [Full Text] [Related]
17. Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE. Mindur JE, Ito N, Dhib-Jalbut S, Ito K. PLoS One; 2014 Oct 15; 9(6):e99068. PubMed ID: 24896098 [Abstract] [Full Text] [Related]
18. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. Yu M, Johnson JM, Tuohy VK. J Exp Med; 1996 Apr 01; 183(4):1777-88. PubMed ID: 8666934 [Abstract] [Full Text] [Related]
19. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis. Tian J, Song M, Kaufman DL. Sci Rep; 2021 Mar 08; 11(1):5402. PubMed ID: 33686135 [Abstract] [Full Text] [Related]